Her3 is commonly co-expressed with Her2 in breast cancer [40]; it is crucial for luminal mammary epithelium cell viability [41] and therefore, plays a pivotal role in cell growth and survival in Her2-dependent breast cancers [42]. Here, ERBB3 is linked to breast carcinoma.